DOCSLIB.ORG

95489 Coventry Health Care of Kansas, Inc. Original Filing Quarter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
95489 Coventry Health Care of Kansas, Inc. Original Filing Quarter STATEMENT AS OF MARCH 31, 2021 OF THE Coventry Health Care of Kansas, Inc. ASSETS Current Statement Date 4 1 2 3 December 31 Net Admitted Assets Prior Year Net Assets Nonadmitted Assets (Cols. 1 - 2) Admitted Assets 1. Bonds 11,977,095 0 11,977,095 12,067,386 2. Stocks: 2.1 Preferred stocks 0 0 0 0 2.2 Common stocks 0 0 0 0 3. Mortgage loans on real estate: 3.1 First liens 0 0 0 0 3.2 Other than first liens 0 0 0 0 4. Real estate: 4.1 Properties occupied by the company (less $ 0 encumbrances) 0 0 0 0 4.2 Properties held for the production of income (less $ 0 encumbrances) 0 0 0 0 4.3 Properties held for sale (less $ 0 encumbrances) 0 0 0 0 5. Cash ($ 14,196,183 ), cash equivalents ($ 12,590,597 ) and short-term investments ($ 0 ) 26,786,780 0 26,786,780 24,818,610 6. Contract loans (including $ 0 premium notes) 0 0 0 0 7. Derivatives 0 0 0 0 8. Other invested assets 0 0 0 0 9. Receivables for securities 0 0 0 0 10. Securities lending reinvested collateral assets 0 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 38,763,875 0 38,763,875 36,885,996 13. Title plants less $ 0 charged off (for Title insurers only) 0 0 0 0 14. Investment income due and accrued 70,910 0 70,910 71,505 15. Premiums and considerations: 15.1 Uncollected premiums and agents' balances in the course of collection 365,354 3,752 361,602 241 15.2 Deferred premiums, agents' balances and installments booked but deferred and not yet due (including $ 0 earned but unbilled premiums) 0 0 0 0 15.3 Accrued retrospective premiums ($ 129,118 ) and contracts subject to redetermination ($ 2,247,222 ) 2,376,340 0 2,376,340 1,144,139 16. Reinsurance: 16.1 Amounts recoverable from reinsurers 0 0 0 0 16.2 Funds held by or deposited with reinsured companies 0 0 0 0 16.3 Other amounts receivable under reinsurance contracts 0 0 0 0 17. Amounts receivable relating to uninsured plans 1,936,958 0 1,936,958 2,019,780 18.1 Current federal and foreign income tax recoverable and interest thereon 0 0 0 0 18.2 Net deferred tax asset 3,975,703 1,928,044 2,047,659 2,087,167 19. Guaranty funds receivable or on deposit 0 0 0 0 20. Electronic data processing equipment and software 0 0 0 0 21. Furniture and equipment, including health care delivery assets ($ 0 ) 321,065 321,065 0 0 22. Net adjustment in assets and liabilities due to foreign exchange rates 0 0 0 0 23. Receivables from parent, subsidiaries and affiliates 235 235 0 0 24. Health care ($ 1,837,324 ) and other amounts receivable 1,858,572 21,248 1,837,324 1,063,201 25. Aggregate write-ins for other than invested assets 963,202 0 963,202 437,645 26. Total assets excluding Separate Accounts, Segregated Accounts and Protected Cell Accounts (Lines 12 to 25) 50,632,214 2,274,344 48,357,870 43,709,674 27. From Separate Accounts, Segregated Accounts and Protected Cell Accounts 0 0 0 0 28. Total (Lines 26 and 27) 50,632,214 2,274,344 48,357,870 43,709,674 DETAILS OF WRITE-INS 1101. 1102. 1103. 1198. Summary of remaining write-ins for Line 11 from overflow page 0 0 0 0 1199. Totals (Lines 1101 through 1103 plus 1198)(Line 11 above) 0 0 0 0 2501. Recoverable state premium taxes 963,202 0 963,202 437,645 2502. 2503. 2598. Summary of remaining write-ins for Line 25 from overflow page 0 0 0 0 2599. Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) 963,202 0 963,202 437,645 2 STATEMENT AS OF MARCH 31, 2021 OF THE Coventry Health Care of Kansas, Inc. LIABILITIES, CAPITAL AND SURPLUS Current Period Prior Year 1 2 3 4 Covered Uncovered Total Total 1. Claims unpaid (less $ 49,869 reinsurance ceded) 10,982,464 1,604,887 12,587,351 8,281,666 2. Accrued medical incentive pool and bonus amounts 40,000 0 40,000 31,901 3. Unpaid claims adjustment expenses 135,881 0 135,881 95,989 4. Aggregate health policy reserves, including the liability of $ 1,946,714 for medical loss ratio rebate per the Public Health Service Act 2,503,519 0 2,503,519 2,969,662 5. Aggregate life policy reserves 0 0 0 0 6. Property/casualty unearned premium reserve 0 0 0 0 7. Aggregate health claim reserves 0 0 0 0 8. Premiums received in advance 0 0 0 6,986 9. General expenses due or accrued 1,042,334 0 1,042,334 1,106,834 10.1 Current federal and foreign income tax payable and interest thereon (including $ 0 on realized gains (losses)) 701,837 0 701,837 3,354,310 10.2 Net deferred tax liability 0 0 0 0 11. Ceded reinsurance premiums payable 0 0 0 0 12. Amounts withheld or retained for the account of others 0 0 0 0 13. Remittances and items not allocated 33,852 0 33,852 120,474 14. Borrowed money (including $ 0 current) and interest thereon $ 0 (including $ 0 current) 0 0 0 0 15. Amounts due to parent, subsidiaries and affiliates 1,586,678 0 1,586,678 926,795 16. Derivatives 0 0 0 0 17. Payable for securities 0 0 0 0 18. Payable for securities lending 0 0 0 0 19. Funds held under reinsurance treaties (with $ 51,225 authorized reinsurers, $ 0 unauthorized reinsurers and $ 0 certified reinsurers) 51,225 0 51,225 22,052 20. Reinsurance in unauthorized and certified ($ 0 ) companies 0 0 0 0 21. Net adjustments in assets and liabilities due to foreign exchange rates 0 0 0 0 22. Liability for amounts held under uninsured plans 680,960 0 680,960 0 23. Aggregate write-ins for other liabilities (including $ 0 current) 114,807 0 114,807 117,871 24. Total liabilities (Lines 1 to 23) 17,873,557 1,604,887 19,478,444 17,034,540 25. Aggregate write-ins for special surplus funds XXX XXX 0 0 26. Common capital stock XXX XXX 5,000 5,000 27. Preferred capital stock XXX XXX 0 0 28. Gross paid in and contributed surplus XXX XXX 125,271,800 125,271,800 29. Surplus notes XXX XXX 0 0 30. Aggregate write-ins for other than special surplus funds XXX XXX 0 0 31. Unassigned funds (surplus) XXX XXX (96,397,374) (98,601,666) 32. Less treasury stock, at cost: 32.1 0 shares common (value included in Line 26 $ 0 ) XXX XXX 0 0 32.2 0 shares preferred (value included in Line 27 $ 0 ) XXX XXX 0 0 33. Total capital and surplus (Lines 25 to 31 minus Line 32) XXX XXX 28,879,426 26,675,134 34. Total liabilities, capital and surplus (Lines 24 and 33) XXX XXX 48,357,870 43,709,674 DETAILS OF WRITE-INS 2301. Escheat payable 114,807 0 114,807 117,871 2302. 2303. 2398. Summary of remaining write-ins for Line 23 from overflow page 0 0 0 0 2399. Totals (Lines 2301 through 2303 plus 2398)(Line 23 above) 114,807 0 114,807 117,871 2501. XXX XXX 0 0 2502. XXX XXX 2503. XXX XXX 2598. Summary of remaining write-ins for Line 25 from overflow page XXX XXX 0 0 2599. Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) XXX XXX 0 0 3001. XXX XXX 0 0 3002. XXX XXX 3003. XXX XXX 3098. Summary of remaining write-ins for Line 30 from overflow page XXX XXX 0 0 3099. Totals (Lines 3001 through 3003 plus 3098)(Line 30 above) XXX XXX 0 0 3 STATEMENT AS OF MARCH 31, 2021 OF THE Coventry Health Care of Kansas, Inc. STATEMENT OF REVENUE AND EXPENSES Current Year Prior Year Prior Year Ended To Date To Date December 31 1 2 3 4 Uncovered Total Total Total 1. Member Months XXX 16,722 6,701 38,211 2. Net premium income ( including $ 0 non-health premium income) XXX 27,189,517 10,711,128 68,361,483 3. Change in unearned premium reserves and reserve for rate credits XXX (51,123) 1,100,000 (422,574) 4. Fee-for-service (net of $ 0 medical expenses) XXX 0 0 0 5. Risk revenue XXX 0 0 0 6. Aggregate write-ins for other health care related revenues XXX 0 0 0 7. Aggregate write-ins for other non-health revenues XXX 0 0 0 8. Total revenues (Lines 2 to 7) XXX 27,138,394 11,811,128 67,938,909 Hospital and Medical: 9. Hospital/medical benefits 2,062,338 16,175,198 4,103,459 29,146,542 10. Other professional services 203,868 1,598,967 202,327 4,016,052 11. Outside referrals 109,234 856,736 226,778 1,585,063 12. Emergency room and out-of-area 146,639 1,150,108 445,725 2,397,332 13. Prescription drugs 0 2,669,455 944,031 4,908,519 14. Aggregate write-ins for other hospital and medical 0 0 0 0 15.
Load more

Recommended publications
  • CVS Health Announces COVID-19 Resources for Aetna Members
    CVS Health announces COVID-19 resources for Aetna members In response to the rapidly evolving COVID-19 outbreak, CVS Health announced a series of steps designed to support the health and well-being of Aetna members, ensure patient access to medication, and remove barriers to care. Effective immediately: Aetna will waive co-pays for all diagnostic testing related to COVID-19. This policy will cover the cost of physician-ordered testing for patients who meet CDC guidelines, which can be done in any approved laboratory location. Aetna will waive the member costs associated with diagnostic testing for all Commercial (including small group Aetna Funding Advantage, AFA), Medicare and Medicaid lines of business. Self-insured plan sponsors will be able to opt-out of this program at their discretion. For the next 90 days, Aetna will offer zero co-pay telemedicine visits for any reason. Aetna members should use telemedicine as their first line of defense in order to limit potential exposure in physician offices. Cost sharing will be waived for all virtual visits through Aetna-covered Teladoc® offerings and in-network providers delivering synchronous virtual care (live videoconferencing) for all Commercial plan designs, including small group Aetna Funding Advantage. Self-insured plan sponsors will be able to opt-out of this program at their discretion. CVS Pharmacy will waive charges for home delivery of prescription medications. With the Centers for Disease Control and Prevention encouraging people at higher risk for COVID-19 complications to stay at home as much as possible, this is a convenient option to avoid coming to the pharmacy for refills or new prescriptions.
    [Show full text]
  • TC-017 Butterfield, Dawn (National Community Pharmacy Association)
    Peter Mucchetti, Chief Healthcare and Consumer Products Section, Antitrust Division Department of Justice 450 Fifth Street NW, Suite 4100 Washington, DC 20530 December 13, 2018 Dear Judge Leon: Thank you so much for inviting or allowing comments on the proposed CVS/Aetna merger. We (pharmacy owners/pharmacists) were not happy when our own organization - NCPA - National Community Pharmacy Association was referenced in the Congressional Hearing on this merger earlier in the year that "we were fine" with the merger as expressed by Tom Moriarty - CVS General Counsel to the Congressional Committee. This most assuredly is NOT the case I can assure you. However that was communicated - and not clarified by our association is an issue we are all still highly upset about as I believe that was the time to publicly state our vehement opposition to this merger. In other words, a major ball was dropped and a bell was rung that couldn't be unrung. That being said - we, as business owners and professionals don't know how we can state our issues - which are numerous and we were being told by virtually everyone that the merger is a "done deal" as the FTC and DOJ didn't have an issue with it. I hope you receive communication from people who took the time to do so. Some people are frozen and/or feel defeated as they believe there's nothing to stop this train and have given up. I can say with certainty that for every letter from a pharmacist/pharmacy owner/pharmacy professor - there were 1000 that went along with it! I'm enclosing some material you may already have, but the infographic on the states shows to the extent of what can happen when your competition sets YOUR price.
    [Show full text]
  • Directions to Walgreens Closest to My Location
    Directions To Walgreens Closest To My Location Tinglier Corky sometimes release his rockweed whencesoever and unburdens so vertically! Zollie still herborized deathy while manufactured Morty feeds that equivalent. Andonis is dispossessed: she backspacing austerely and stole her kaiserdom. Click continue to caring spirit of apple inc in no es responsable, family can i try passport applicants when used the content provided in my walgreens subsidiary that the features plenty of dissimilar metals which typically covered drugs safer and You can replicate search Walgreens 24 hour Pharmacy Near tree in Google Maps to get. Drive-Thru Testing Available by Appointment Snohomish. Please arrive in my walgreens locations offer all states that location for direct to encourage you can. The lenawee county program manager at walgreens customer service to target resource does not boil dry in. Members and walgreens locations only testing site is located in my results found for breaking news tip direct or an inference may take advantage of. The prophet time fix it operates is when ordinary water intake all out during the vaporizer. Error has issued a large corporation is your eligibility requirements here and operated by a launch pad to perform the closest location to walgreens my facility type of the final arbiter of. Us to my experience. Fees and limits apply. We are located in to drive to treat the closest location. List Close menu Find retail Store Prescriptions Back Prescriptions Refills Order Status Records Transfer of New Auto Refills Drug Info Getting. Each vaccination team being responsible for different own scheduling and paperwork. American nurses credentialing center is to my results to proceed, locations or location and.
    [Show full text]
  • CVS Health Code of Conduct 1 CVS Health Code of Conduct 2 What We Stand For
    Code of Conduct Dear CVS Health® Colleagues Over the years CVS Health has built an outstanding reputation with our customers, colleagues and key stakeholders. Our reputation for superior customer service and excellence in execution, coupled with our high level of integrity and sound business practices have helped us build a solid foundation of trust. This foundation is a valuable asset that has taken years to build, and is vital to our long-term success. As we look toward the future, we remain steadfast in our commitment to doing the right things in the right way, complying with laws and regulations and never compromising our standards. As you go about your day-to-day work and deal with challenging issues, I encourage you to refer to our Code. The Code was designed to help establish appropriate “rules of the road” for colleagues looking for the right solutions to ethical questions or issues and in obtaining additional guidance when the correct path is not clear. Each of your decisions and actions shape our reputation at CVS Health. That is why we must all commit to act with integrity while meeting our responsibilities. The Code is an excellent guide to doing the right thing, but it is not a substitute for good judgment, nor can it address every issue. So where there is no written rule or precedent, decisions need to be consistent with our company’s Purpose, Strategy and Values, which represent our guiding principles as an organization. In doing so we will continue to earn the trust that our stakeholders have placed in us.
    [Show full text]
  • CVS Health Corporation Corporate Integrity Agreement
    CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND CVS HEALTH CORPORATION I. PREAMBLE CVS Health Corporation and its subsidiaries (collectively, “CVS Health”) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements). CVS Health is an integrated pharmacy services health care provider engaged in certain business lines that do business with Federal health care programs. Except as otherwise specified herein, the terms of this CIA shall apply to Omnicare, Inc. and its operating subsidiaries, which is CVS Health’s business line of institutional pharmacy services operations (“IPS Operations”), as defined in Section II.C.1, below. Effective August 18, 2015, CVS Health acquired Omnicare, Inc. Contemporaneously with this CIA, Omnicare, Inc. is entering into a Settlement Agreement with the United States. In consideration of the obligations of CVS Health in this CIA and the obligations set forth in the settlement agreement entered into among the United States of America, acting through the United States Department of Justice and on behalf of the OIG-HHS; Omnicare, Inc.; NCS Healthcare, LLC; NeighborCare, Inc.; and Relators Donald Gale and Marc Silver on June 25, 2014 (hereinafter “2014 Omnicare Settlement Agreement”), OIG agrees to release and refrain from instituting, directing, or maintaining any administrative action seeking exclusion from Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C.
    [Show full text]
  • Net Lease Pharmacy Report March 2018
    Net Lease Pharmacy Report March 2018 NET LEASE PHARMACY INDUSTRY OVERVIEW CVS and Walgreens are the market leaders in the U.S. drugstore industry accounting for more than half of the market share in top metropolitan areas. Over the years, drugstores have evolved into all- encompassing health service providers and as a result have strategically positioned themselves to diversify their portfolios by acquiring key competitors and forging partnerships to protect themselves from growing online threat. Industry demand is driven by an aging population, health issues, and ad- vances in medical treatment. Drugstores rely heavily on their prescription business, which has grown over the years, however same store comparables for front of store sales have decreased. Total 2017 retail sales for prescription drugs filled at pharmacies surpassed $397B* and are speculated to have been upwards of $426B. *Data based on QuintilesIMS National Prescription Audit (NPA) database. Includes new prescriptions and refills of both brand/generic. Source: Kaiser Foundation Definitions Pharmacy Benefits Managers (PBM): Third party companies that provide healthcare management and administration services to insurance companies, Medicare Part D plans, state government employee plans and corporations. e.g. CVS Caremark, Express Scripts. PBMs lever- age economies of scale by negotiating drug prices with drug makers and pharmacies on behalf of larger groups of customers. Chad M. Firsel Daniel Waszak Jason Caplan Zack Hilgendorf Jack Farritor President Senior Vice President Senior Vice President Vice President Vice President 312.269.0220 312.269.0550 312.533.2347 312.533.2348 312.683.9924 [email protected] [email protected] [email protected] [email protected] [email protected] Quantum Real Estate Advisors, Inc.
    [Show full text]
  • CVS Pharmacy
    CVS Pharmacy 6705 East Lake Meade Blvd, Las Vegas, NV 89156 Price: $5,185,185 | Cap: 5.4% | Bond Triple Net Rent: 280,000 • Over 12 years remaining on Absolute Bond Net Lease • Last three years of base lease term are prepaid • 5.9% yield day one • Located in one of the strongest markets in the US • Highly visible hard corner with over 31,000 vehicles per day Phone: 212.686.0072 • Population of 278,500 within 5 miles of the property Fax: 212.686.0078 • Steady increases in population and average household income [email protected] • Drive-through prescription window and on-site liquor sales www.exp1031.com • 7-Eleven, Chevron and Dollar Tree are all on the intersection with the CVS This information has been obtained from sources deemed reliable, however EXP Realty Advisors does not guarantee, warranty or represent its accuracy. It is the Purchaser’s responsibility to independently confirm the accuracy and completeness of the information contained herein. CVS Pharmacy – Las Vegas, NV Investment Overview EXP Realty Advisors exclusively presents for sale a freestanding CVS drugstore located at 6705 East Lake Mead Boulevard Las Vegas Nevada. The bond net lease has over 12 years of remaining lease term. The property is a pad site to an Albertsons anchored supermarket. The property is its own parcel and not subject to any restrictions. East Lake Mead Boulevard has over 20,000 vehicles per day and N. Hollywood Blvd has 11,700 VPD and is part of the Northeast Las Vegas submarket of Las Vegas. The building was built in 1999 and sits on 1.4 acre.
    [Show full text]
  • Form a Application of CVS Health Corp. for Acquisition of Aetna Better
    Exhibit 4-C Item 1 of CVS Health's 2014 Annual Report on Form 10-K PART I Item I. Business Overview CVS Health Corporation, together with its subsidiaries (collectively "CVS Health," the "Company," "we," "uur" ur "us"), is a pharmacy innovation company helping people on their path to better health. At the forefront of a changing health care landscape, the Company has an unmatched suite of capabilitics and the expertise needed to drive innovations that will help shape the future of health. We arc currently the only integrated pharmacy health care company with the ability to impact consumers, payors, and providers with innovative, channel-agnostic solutions. We have a deep understanding of their diverse needs through our unique integrated model, and we arc bringing them innovative solutions that help increase access to quality care, deliver better health outcomes, and lower overall health care costs. Through our 7,800 retail phannacics, more than 900 walk-in medical clinics. a leading pharmacy benefits manager with more than 65 million plan members, and expanding specialty pharmacy services. we enable people, businesses. and communities to manage health in more effective ways. We arc delivering break-through products and services, from advising patients on their medications at our CVS/pharmacy" locations, to introducing unique programs to help control costs for our clients at CVS/carcmark, to innovating how care is delivered to our patients with complex conditions through CVS/specialty, or by expanding access to high-quality, low-cost care at CVS/minuteclinic. We currently have three reportable segments: Pharmacy Services, Retail Pharmacy and Corporate.
    [Show full text]
  • Commonwealth of Kentucky Franklin Circuit Court, Div. _____ Civil Action No
    COMMONWEALTH OF KENTUCKY FRANKLIN CIRCUIT COURT, DIV. _____ CIVIL ACTION NO. _______________ COMMONWEALTH OF KENTUCKY, ex. rel. DANIEL CAMERON, ATTORNEY GENERAL, Plaintiff, v. CVS HEALTH CORPORATION, a Delaware corporation; Serve: The Corporation Trust Company 1209 Orange Street Wilmington, Delaware 19801 CVS PHARMACY, INC., a Rhode Island corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 CVS TN DISTRIBUTION LLC, a Tennessee corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 CVS INDIANA, LLC, an Indiana corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 and KENTUCKY CVS PHARMACY, LLC, a Kentucky corporation, Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 Defendants. COMPLAINT JURY TRIAL DEMANDED TABLE OF CONTENTS I. INTRODUCTION .............................................................................................................. 1 II. PARTIES ............................................................................................................................ 6 III. JURISDICTION AND VENUE ......................................................................................... 8 IV. FACTUAL BACKGROUND ........................................................................................... 10 A. CVS’s Key Roles In The Opioid Supply Chain Requires Them To Adhere To Legal Duties Designed To Protect Public Health And Safety ...............................10
    [Show full text]
  • TESTIMONY of CRAIG L. GARTHWAITE, Ph.D. Associate
    TESTIMONY OF CRAIG L. GARTHWAITE, Ph.D. Associate Professor of Strategy Herman Smith Research Professor in Hospital and Health Services Management Director of Health Enterprise Management Program (HEMA) Kellogg School of Management Northwestern University Before the House Judiciary Committee Subcommittee on Regulatory Reform, Commercial and Antitrust Law On “Competition in the Pharmaceutical Supply Chain: The Proposed Merger of CVS Health and Aetna” February 27, 2018 1 SUMMARY OF STATEMENT • I am here today to discuss the potential economic implications and rationales for the proposed merger of CVS Health and Aetna. This merger will combine the assets of a pharmacy benefit manager, health insurer, chain of retail pharmacies, chain of minute clinics, and a variety of other assets into a single firm. • CVS-Aetna is a vertical merger. i.e. firms at the same stage of the value chain that are proposing to combine into a single entity. Unlike horizontal mergers (i.e. firms at the same stage of the value chain merging such as the recently opposed Anthem-Cigna and Aetna-Humana merger) the theory and the empirical evidence regarding the impacts of vertical mergers on social welfare is relatively ambiguous. • Vertically integrating firms choose to avoid the market in favor using an internal supplier (this is often referred to colloquially as a “make or buy” decision for the firm). This decision is often met with skepticism by economists and strategy professionals. This skepticism arises from the fact that a well-functioning economic market is efficient in that it provides the appropriate incentives for a good or service of a particularly quality to be produced by the lowest cost firm at the lowest possible price.
    [Show full text]
  • 1 United States District Court Southern
    UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ) _____ Individually and On Behalf of All ) Others Similarly Situated, ) Case No. ) Plaintiff, ) ) CLASS ACTION COMPLAINT v. ) ) ) CVS HEALTH CORPORATION, LARRY J. ) JURY TRIAL DEMANDED MERLO, and DAVID M. DENTON, ) ) ) Defendants. ) ) Plaintiff_____ (“Plaintiff”), individually and on behalf of all other persons similarly situated, by Plaintiff’s undersigned attorneys, for Plaintiff’s complaint against Defendants, alleges the following based upon personal knowledge as to Plaintiff and Plaintiff’s own acts, and information and belief as to all other matters, based upon, inter alia, the investigation conducted by and through Plaintiff’s attorneys, which included, among other things, a review of the Defendants’ public documents, conference calls and announcements made by Defendants, United States Securities and Exchange Commission (“SEC”) filings, wire and press releases published by and regarding CVS Health Corporation (“CVS Health” or the “Company”), analysts’ reports and advisories about the Company, and information readily obtainable on the Internet. Plaintiff believes that substantial evidentiary support will exist for the allegations set forth herein after a reasonable opportunity for discovery. NATURE OF THE ACTION 1. This is a federal securities class action on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the “Class Period”), seeking to recover 1 damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
    [Show full text]
  • CVS Health Corporation (NYSE: CVS) Sector: Healthcare Target Price Current Price 52 Week High 52 Week Low P/E Market Cap
    CVS Health Corporation (NYSE: CVS) Sector: Healthcare Target Price Current Price 52 Week High 52 Week Low P/E Market Cap. Dividend Yield Adj.Beta $95.24 $81.41 $106.10 $73.53 14.87 $83.164 B 2.47% .756 Business Description CVS Health Corporation is an integrated pharmacy health care Corporate Social Responsibility provider. The Company’s offerings include pharmacy benefit Independent Chairperson: 1.00, Yes (Industry Average: 0.25) management services, mail order, retail and specialty pharmacy, % of Non-Exec Directors on Board: 90.91% (Industry Average: 88.03) disease management programs and retail clinics. The company Chief Financial Officer Tenure: 6.00 (Industry Average: 3.06) operates Drugstores through the United States and Puerto Rico. The company has three reportable segments. These are the Pharmacy 5-Year Stock Performance Services segment, the Retail/LTC Segment and the Corporate segment. Revenue is only recorded in the Pharmacy Services and Retail Segments. The pharmacy services segment offers pharmacy benefit management solutions to clients, which consist of employers, insurance companies, unions, etc. They operate a SilverScript subsidiary which is a drug beneficiary for the Medicare Part D Program. In 2016, this segment filled and managed 1.2 billion prescriptions. This business seeks to use innovative tools and quality client service to improve clinical outcomes for health benefit plan members, while assisting their members to better manage costs. PBM services include Maintenance Choice, Pharmacy Advisor, Specialty Connect, Extra Care Health Card program, and MinuteClinic. The Retail/LTC segment dispenses prescriptions and provides services. Competitive Analysis This segment accounts for two-thirds of the company’s revenue.
    [Show full text]